Journal Information

Statistics

Follow this link to access the full text of the article

OUTPATIENT SUBCUTANEOUS ALEMTUZUMAB IS FEASIBLE AND SAFE FOR APLASTIC ANEMIA AND ASSOCIATED WITH HIGH RESPONSE RATES
AR Fonsecaa,b, CC Justinoa, VC Mollaa,c, PE Yamakawaa, IB Rabeloa, A Hilld, L Arnoldd, R Kellyd, M Griffind, T Munird, E Vellosoe, T Dalessandroe, AM Risitanof,g, P Scheinbergh, A Kulasekararaji, C Arrais-Rodriguesa,c
a Universidade Federal de São Paulo (UNIFESP), São Paulo, Brazil
b Hospital Sírio Libanês, São Paulo, Brazil
c Hospital Nove de Julho, São Paulo, Brazil
d Department of Haematology, St James's University Hospital, Leeds, United Kingdom
e Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo (HCFMUSP), São Paulo, Brazil
f Department of Clinical Medicine and Surgery, University of Naples, Naples, Italy
g Severe Aplastic Anemia Working Party, European Group for Blood and Marrow Transplantation (EBMT), Leiden, Netherlands
h Division of Hematology, Hospital A Beneficência Portuguesa, São Paulo, Brazil
i King's College Hospital NHS Foundation Trust, London, United Kingdom
Ver más
Read
1001
Times
was read the article
360
Total PDF
641
Total HTML
Share statistics
Article information
ISSN: 25311379
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2025 May 17 6 23
2025 April 41 12 53
2025 March 56 13 69
2025 February 52 14 66
2025 January 36 24 60
2024 December 28 12 40
2024 November 44 12 56
2024 October 42 26 68
2024 September 43 19 62
2024 August 52 17 69
2024 July 39 22 61
2024 June 34 19 53
2024 May 45 41 86
2024 April 33 17 50
2024 March 28 21 49
2024 February 18 22 40
2024 January 7 14 21
2023 December 11 18 29
2023 November 13 23 36
2023 October 2 8 10
Show all

Follow this link to access the full text of the article

Idiomas
Hematology, Transfusion and Cell Therapy